Does insurance cover testosterone replacement therapy? Usually yes, but only when your chart proves a diagnosis the plan recognizes. Most commercial drug plans treat testosterone as a covered prescription for male hypogonadism and nothing else, and they check the paperwork before they pay. Two low early-morning lab results plus documented symptoms is the standard bar. A single afternoon test, a general complaint of low energy or a goal like better gym performance will not clear it. Paperwork decides this.
Quick answer: Many plans cover testosterone therapy for diagnosed hypogonadism, usually after prior authorization. Expect the insurer to ask for two low total testosterone results drawn on separate mornings, a record of symptoms, and baseline safety labs. Use for athletic performance is excluded. If a claim is denied, you can file an internal appeal and then request an independent external review. Prescribed testosterone is generally an HSA and FSA eligible expense.
Does insurance cover testosterone replacement therapy for every man with low T?
No. Coverage follows the diagnosis, not the symptom list. The Proactive Choice testosterone page says it plainly: most plans do not cover testosterone therapy unless the diagnosis meets specific medical criteria, and even then coverage varies by carrier.
Look at how two large plans write it. The Cigna prior authorization policy for injectable testosterone (effective September 17, 2025) approves treatment for a man with persistent signs and symptoms of androgen deficiency and two low morning testosterone levels taken on two separate days. The same policy excludes testosterone used to boost athletic performance. An Express Scripts policy for oral, topical and nasal testosterone uses nearly identical wording and adds that uses not listed in its criteria are not recommended for approval.
So when someone asks, “is testosterone replacement therapy covered by insurance?”, the useful answer is conditional. It is covered for a documented medical condition. It is not covered as a general wellness or performance product, and the insurer decides which one you are from what your clinician sends.
The low bar most policies point to comes from the American Urological Association testosterone deficiency guideline, which calls a total testosterone below 300 ng/dL a reasonable cut-off and says the diagnosis should be made only after two early-morning measurements on separate occasions. The Endocrine Society guideline (Bhasin et al., 2018) asks for the same pattern: symptoms plus unequivocally and consistently low total testosterone, confirmed with a repeat fasting morning test.
TRT insurance coverage checklist: what insurers ask for
Policies differ in the details. The items below show up again and again across the Cigna, Express Scripts and Federal Employee Program policies reviewed for this article, so treat them as the likely paper trail.
- Two total testosterone results, drawn in the morning on different days, both below the lab’s normal range. The Federal Employee Program policy for topical testosterone (effective July 1, 2026) is stricter: both draws between 8:00 and 10:00 a.m., and both under 300 ng/dL.
- Symptoms written into the chart before treatment, such as low libido, low energy, depressed mood or loss of muscle mass.
- A baseline PSA for men over 40 and a hematocrit result. The AUA guideline recommends both before therapy starts, and the FEP policy sets limits on each.
- A cardiovascular risk review and a note that untreated sleep apnea is not present (FEP).
- An LH level, which the AUA guideline recommends in every man with low testosterone because it helps separate testicular causes from pituitary ones.
- The diagnosis code for hypogonadism, not a vague code for fatigue.
Gaps get noticed. If one item is missing, expect the request to come back for more records. That sounds bureaucratic, and it is, but the list is also a fair description of a careful workup.
How prior authorization works for testosterone
HealthCare.gov defines prior authorization as approval from a health plan that may be required before you get a service or fill a prescription in order for it to be covered. In practice, the pharmacy runs your prescription, the claim rejects with a prior authorization flag, and your prescriber’s office submits a form with the labs and chart notes listed above. You wait.
Approval does not last forever
Approvals are time-limited. Cigna’s initial approval runs one year. The FEP topical policy approves six months to start, then renews in 12-month blocks if the on-treatment testosterone level is 800 ng/dL or less and PSA, hematocrit and testosterone are checked every year. At renewal the plan wants proof that treatment is being monitored, on top of proof that the original diagnosis was right.
Switching plans means proving it again
A new insurer does not inherit the old one’s approval. The Express Scripts policy handles men already on testosterone by asking for documented pre-treatment symptoms and at least one low testosterone level from before therapy began. If those original labs were never done, or were done once in the afternoon, there may be nothing to send.
That is the strongest argument for doing the evaluation properly even if you plan to pay out of pocket today. Jobs change. Employer plans change at open enrollment. The two morning lab results you skip this year are the ones a future insurer will ask for, and you cannot go back and draw them once you are on treatment.
Is testosterone therapy covered by insurance for age-related low T?
This is the murkiest part of the question right now. For years, FDA labeling for testosterone products carried a limitation of use stating that safety and effectiveness had not been established for age-related hypogonadism. The FDA kept that language when it revised testosterone labels in February 2025.
On June 18, 2026, the Department of Health and Human Services announced that the FDA is requesting label updates that would remove the age-related hypogonadism limitation, narrow the prostate cancer contraindication to metastatic disease, and revise the warnings about enlarged prostate. These are requests to manufacturers. The announcement gives no deadline for the new labels.
Insurance policies are written separately from drug labels and on their own schedules. As of September 2026, the Cigna and FEP policies above still ask for two low morning results and documented symptoms, whatever your age. The Endocrine Society guideline also still suggests against routinely prescribing testosterone to every man 65 or older with low levels, while allowing an individual decision for symptomatic men. Whether insurers loosen their criteria once the labels change is an open question, and nobody outside the plans’ pharmacy committees can answer it yet.
What happens when a TRT claim is denied
Read the denial letter first. It will name a reason, and the reason decides the fix.
Some denials are about missing paperwork, such as one lab instead of two or no symptom notes. Your prescriber can often resubmit with the missing records. Others are step therapy or formulary denials, meaning the plan wants you to try a preferred product first. A formulary is simply the plan’s list of covered prescription drugs.
A New York external appeal decision (case 202108-140376, published by the state Department of Financial Services) shows how that second type can play out. A man in his 70s with testicular hypofunction was denied a testosterone product because his plan required a trial of three formulary alternatives first. The independent reviewer upheld the denial, called the formulary agents acceptable alternatives, and quoted guidance that commercially manufactured testosterone products should be prescribed rather than compounded ones when possible. More paperwork would not have changed that decision. The plan wanted its preferred products tried first.
Your appeal rights
Under federal rules for most non-grandfathered plans, you get two levels of review. According to HealthCare.gov, you have 180 days from the denial notice to file an internal appeal. The insurer must decide within 30 days for a service you have not received yet and within 60 days for one you already received.
If the internal appeal fails, you can ask for an external review by an independent reviewer within four months of the final denial, with standard decisions due within 45 days and expedited ones within 72 hours, and the insurer is required by law to accept the reviewer’s decision. Plans that existed on March 23, 2010 and kept grandfathered status may not follow the same rules, so check your plan documents.
An appeal is strongest when the chart shows exactly what the policy asks for. Feeling better on treatment is not one of the criteria.
Can you use an HSA or FSA for testosterone therapy?
Generally, yes. IRS Publication 502 counts prescribed drugs as medical expenses and defines a prescribed drug as one that requires a prescription by a doctor for its use by an individual. Testosterone is a prescription drug, so it fits that definition. The same publication counts laboratory fees that are part of medical care, which covers the morning blood draws and follow-up labs. IRS Publication 969 ties HSA qualified expenses to that same medical care definition.
Two limits matter. HSA money spent on something that is not a qualified medical expense is taxable and carries an additional 20% tax unless you are 65 or older or disabled. And the IRS definition does not depend on your insurer’s approval, so HSA or FSA funds can still help when a claim is denied or when you see a provider outside your network. The Proactive Choice guide to HSA and FSA rules for naturopathic care covers visits and lab testing in more detail, and the office can help you work out what documentation your account administrator wants.
Keep every receipt. Administrators ask.
Getting evaluated in a way an insurer will accept
Nearly every requirement above depends on the lab work being done right. A morning draw, repeated on a second morning, read alongside symptoms, is what the AUA and Endocrine Society guidelines describe and what insurers copy into their policies. Our guide on how testosterone is tested walks through timing, fasting and why one result is not enough.
At Proactive Choice, Dr. Collins follows that same pattern: an early-morning total testosterone test repeated on a second morning, with fuller hormone labs that include free testosterone, SHBG, estradiol, LH and FSH plus a metabolic panel, and treatment only when results are consistently low and symptoms fit. Labs are repeated every six months once treatment starts. For how coverage works for naturopathic visits in general, see our page on insurance coverage for naturopathic care in Oregon.
Frequently asked questions
Does insurance cover TRT if I have symptoms but normal labs?
Usually not. The Cigna and Express Scripts policies both require two low morning testosterone results on separate days in addition to symptoms, and the FEP topical policy requires both results to be under 300 ng/dL. Symptoms alone do not meet the diagnostic standard in the AUA or Endocrine Society guidelines, so an insurer has no diagnosis to approve.
Is testosterone therapy covered by insurance through Medicare?
Some Medicare Part D drug plans cover testosterone with prior authorization. An Aetna Medicare Part D form, for example, asks for at least two confirmed low testosterone levels based on practice guidelines or standard lab reference values, and approves through the end of the plan contract year. Check your own plan’s drug list, because each Part D plan sets its own criteria.
How long does prior authorization take?
It depends on the plan and on how complete the first submission is, so send both morning labs and the symptom notes the first time. If the request is denied, federal rules give the insurer 30 days to decide an internal appeal for a prescription you have not filled yet, and expedited reviews exist for urgent medical situations.
Does insurance cover testosterone for bodybuilding or athletic performance?
No. The Cigna and Express Scripts prior authorization policies both exclude athletic performance as a covered use. Coverage is written for men with a documented deficiency: symptoms plus consistently low morning testosterone. A request that describes training goals instead of a diagnosis is very likely to be denied.
Do I need to re-qualify every year?
Most likely. Cigna approves initial therapy for one year. The FEP topical policy approves six months at first and then renews in 12-month periods, provided on-treatment testosterone is 800 ng/dL or less and testosterone, PSA and hematocrit are checked yearly. Keep copies of your monitoring labs so renewals go through without a gap.
If you are sorting out whether your labs and symptoms point to low testosterone, a TRT consultation with Dr. Drew Collins is a practical place to start. Proactive Choice in Bend offers a free 10-minute call with Dr. Collins to talk through whether an evaluation makes sense for you. Call +1 (858) 333-5196.
Sources
- American Urological Association: Evaluation and Management of Testosterone Deficiency (2018, validity confirmed 2024)
- Endocrine Society: Testosterone Therapy in Men With Hypogonadism (Bhasin et al., 2018)
- Cigna: Testosterone Injectable Products Prior Authorization Policy
- Express Scripts: Testosterone (Oral, Topical and Nasal) Products Prior Authorization Policy
- Federal Employee Program: Testosterone Topical Policy 5.30.031
- Aetna Medicare Part D: Topical Testosterone Prior Authorization Form
- HHS: FDA Requests Updates to Testosterone Therapy Labeling (June 18, 2026)
- FDA: Class-Wide Labeling Changes for Testosterone Products (February 28, 2025)
- New York Department of Financial Services: External Appeal Case 202108-140376
- HealthCare.gov: Internal Appeals
- HealthCare.gov: External Review
- HealthCare.gov Glossary: Prior Authorization
- IRS Publication 502: Medical and Dental Expenses
- IRS Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans
Medically reviewed content from Proactive Choice. This article is for education and is not a diagnosis. Talk with a licensed clinician about your own labs and symptoms.
Want to talk this through for your own health? Book a visit with Dr. Drew Collins, ND at 601 NW Harmon Blvd in Bend, or call (858) 333-5196.
